Cardinal Health sees 15% revenue growth in Pharma segment, driven by precision medicine and gene therapy.
Cardinal Health's Pharmaceutical and Specialty Solutions segment reported $234.8 billion in revenues for FY2026, up 15% year-over-year and representing 92% of total company revenues. The company is positioned for further growth through its exposure t...
